ELIXIR MD Inc., a medical technology company pioneering proprietary technologies and treatment protocols for post-surgical recovery today announced a strategic partnership with H/K/B Cosmetic Surgery, ...
Paris, May 21, 2025 (GLOBE NEWSWIRE) -- —Sustained durability of treatment effect with significantly lower TLF rates (2.7% versus 7.2%, p=0.030) with DynamX ® compared to DES— —Significantly lower ...